NEGOZIO
logo
+1-4012094076
info@celnovte.com
En
En Cn
NEGOZIO
Casa Prodotto MOLECOLARE PESCARE ETV6/NTRK3 Fusion Gene t (12;15) Probe Reagent (Fluorescence in Situ Hybridization)

Categoria del prodotto

Contattaci

Indirizzo

9430 Key W Ave, Rockville, MD 20850

ETV6/NTRK3 Fusion Gene t (12;15) Probe Reagent (Fluorescence in Situ Hybridization)
ETV6/NTRK3 Fusion Gene t (12;15) Probe Reagent (Fluorescence in Situ Hybridization)

ETV6/NTRK3 Fusion Gene t (12;15) Probe Reagent (Fluorescence in Situ Hybridization)

Clinic Signification：
1. Vitrakvi is the first FDA-approved oral TRK inhibitor to be marketed and also the first "broad-spectrum" anticancer drug that has nothing to do with tumor type. Targeted therapy for patients with NTRK gene (NTRK1/2/3) fusion , including: lung cancer, thyroid cancer, melanoma, gastrointestinal cancer, colon cancer, soft tissue sarcoma, salivary glands, infantile fibrosarcoma, appendix cancer, breast cancer, cholangiocarcinoma, pancreatic cancer etc.

Chiacchierata messaggio Citazione

Contrast

ETV6/NTRK3

NTRK3/ETV6 Fusion

ETV6 Breakpart

Maggiori informazioni

Probe Description: ETV6/NTRK3

Cat.No.: CF1078

Specification: 5 tests/box;10 tests/box, 20 tests/box

Prodotto correlato

7q Deletion Detection Kit

7q Deletion Detection Kit

20q Deletion Detection Kit

20q Deletion Detection Kit

EGR1 Deletion Detection Kit

EGR1 Deletion Detection Kit

EVI Breakapart Detection Kit

EVI Breakapart Detection Kit

Mettiti in contatto

Se hai una richiesta o qualche feedback per noi, compila il modulo sottostante per contattare il nostro team.

superiore